Bigul

TAKE SOLUTIONS LTD. - 532890 - Disclosure Pursuant To Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011.

Please find enclosed herewith the disclosure received from Envestor Ventures Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 2011, for sale of 77,47,194 ( 5.24%) equity shares of TAKE Solutions Limited. You are requested to take the same on your records.
29-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Take Solutions Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
26-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Shareholder Meeting / Postal Ballot-Outcome of AGM

We wish to inform the Stock Exchange that, the Nineteenth Annual General Meeting of the Company was held on September 25, 2020. In this regard, please find enclosed the following: i. Summary of proceedings of the AGM as required under Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 as Annexure - I. ii. Report of Scrutinizer dated September 25, 2020, pursuant to Section 108 of the Companies Act, 2013, read with Rules made thereunder as Annexure - II. iii. Voting Results as required under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - III.
26-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulations 32 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith, the Extract of the Consolidated Unaudited Financial Results for the third quarter ended December 31, 2019, published in newspapers, namely, Financial express (English) and Makkal Kural (Tamil), dated February 14, 2020.
16-09-2020

Earnings Call Transcript - Q1FY21 for Take Solutions

Conference Call with Take Solutions Management and Analysts on Q1FY21 Performance and Financial Outlook. Listen to the full earnings transcript.
16-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Shareholders' Communication

Shareholders' Communication
15-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

We are pleased to enclose a earnings release for your reference and record. Kindly take note of the same.
15-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

The Company has arranged a conference call for Investor(s) and Analyst(s) on Tuesday, September 15, 2020 at 04:00 pm (IST) to discuss the Unaudited Financial Results of the Company for the quarter ended June 30, 2020. A copy of the invitation containing the dial-in details is enclosed herewith for your reference and record. We request you to take note of the aforesaid and acknowledge the receipt.
15-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

With reference to the captioned subject, we would like to inform you that Company's Board has approved, in its Board Meeting held on September 14, 2020, to sell its entire shareholding of 58% in its subsidiary, namely APA Engineering Private Limited.
14-09-2020
Bigul

TAKE SOLUTIONS LTD. - 532890 - Intimation Under Regulation 30 Of SEBI (LODR)

This is to inform that the management of the Company has taken into consideration the impact of known internal and external events arising from COVID-19 pandemic in the assessment of recoverability of trade receivables, contract assets and certain investments in subsidiaries. The liquidity and business constraints, consequent to impact of COVID 19 pandemic, have significantly hampered the operations of a step-down subsidiary viz. Navitas Life Sciences GmbH, Germany (a direct subsidiary of Ecron Acunova Limited and a step- down subsidiary of TAKE Solutions Limited). After assessing the current situation and considering the local requirements, the liquidation process of Navitas Life Sciences GmbH, Germany has been initiated as per the requirements of local laws. Kindly take note of the above.
14-09-2020
Next Page
Close

Let's Open Free Demat Account